RPG Life Sciences Ltd;
25, MIDC Land,
Thane - Belapur Road,
Navi Mumbai - 400 705.
India

Tel: +91 22 2768 1252 / 62 /63
Fax: +91 22 2763 1052 / 2767 2646.

"Process development abilities of the company have generated products that account for almost 70% of the company's turnover." 
Research & Development at RPG Life Sciences is not just limited to developing and improving medications, in fact, it is the strength of the company. 

The chemical R&D, where bulk activities are synthesized, in-housed in a ultra modern building covering about 15,000 sq. ft. area, having state-of-the-art instrumental facilities and is staffed by highly competent scientists many of them trained abroad.

THE PHARMACEUTICAL DEVELOPMENT

Pharmaceutical formulation development department with a floor area 2500 sq.ft. has all modern equipments from dispensing of raw materials upto packing of finished goods, controlled stability chambers with data monitoring system as per ICH guidelines. The development work is carried out in classical pharmaceutical controlled conditions. Highly trained pharmaceutical scientists have been working on formulations development of conventional, critical dosage form of various administrative route. The quality of the product at every step of manufacturing as well as finished product and stability are evaluated by specialised analysts of analytical development of Quality Assurance, using HPLC, GC, UV spectra instruments. The main thrust of development is given on the following area :-

• Designing of Novel Drug Delivery System
• Conventional Dosage Forms
• Critical Conventional Dosage Forms
• Patent non-infringing product for regulated market

Dosage forms developed –

• Specialised drug delivery system
• Solid dosage form
• Liquid dosage form
• Topical formulation
• Injectibles

The company also has modern strain management laboratory. The strains used in production of Biopharmaceuticals are continuously worked upon to improve their yields.

Among the many first’s, the company was able to develop several Doxoubicin, Epirubicin, Pantoprazole, Clopidogrel, Resperidone, Sertralene, Lamotrigene and Quinfadie drugs.

The company has international process patens for Resperidone and Lamotrigene manufacturing processes.

The major success of pharmaceutical formulation development was the designing of Novel Microemulsion technology of Cyclosporine. International patent has been granted to the company for this formulation. The clinical trials in India and in other countries have been found very satisfactory. This product is expected to be the growth engine of company in the future. The other sustained and delayed release products have been developed and launched in India. 

As a part of global business activities, several patent non-infringing products have been developed, launched/to be launched in regulated markets of Europe. 
Launched : Criprofloxacin Tablets, Azathioprine Tablets 
To launch shortly : Lamotrigine formulation, Sertraline formulation